Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Korean Journal of Obstetrics and Gynecology ; : 312-316, 2003.
Artigo em Coreano | WPRIM | ID: wpr-84066

RESUMO

OBJECTIVE: To report our experience with laparoscopically assisted vaginal hysterectomy (LAVH) and evaluate the advantages of LAVH. This is a retrospective study. METHODS: From Jan. 2001 to Aug. 2002, 204 LAVHs were performed at the Department of Obstetrics and Gynecology, Our Lady of Mercy Hospital, The Catholic University of Korea. We studied the results with regard to the age, parity, previous abdominal surgery, surgical indications, operation time, weight of uterus, change of hemoglobin, hospital stay, concomitant procedures, and complications. RESULTS: The mean age was 43.9+/-6.4 years. The mean parity was 2.1+/-1.3. Tubal ligation was most common previous abdominal surgery. As a surgical indication, leiomyoma (52.9%) and adenomyosis (33.3%) were more common indications than any other gynecological problem. The mean operation time was 85.7+/-22.4 minutes. The mean uterine weight was 206.2+/-103.7 g. The mean hemoglobin change was 1.2+/-0.7 g/dl. The mean hospital stay was 3.3+/-0.8 days. Unilateral salpingoophorectomy was most common operation as concomitant procedure. Surgical complication rate was 3.4%. CONCLUSION: LAVH is a safe and effective alternative to abdominal hysterectomy with advanced technologic development in laparoscopic instruments and skills.


Assuntos
Feminino , Adenomiose , Ginecologia , Histerectomia , Histerectomia Vaginal , Coreia (Geográfico) , Leiomioma , Tempo de Internação , Obstetrícia , Paridade , Estudos Retrospectivos , Esterilização Tubária , Útero
2.
Korean Journal of Obstetrics and Gynecology ; : 2118-2122, 2003.
Artigo em Coreano | WPRIM | ID: wpr-79250

RESUMO

OBJECTIVE: The purpose of this study was to evaluate value of methotretrexate (MTX) in the treatment of tubal pregnancy. METHODS: 28 patients with unruptured tubal pregnancy were treated alternately with four doses of intramuscular MTX (1.0 mg/kg) and four doses of intramuscular citrovorum factor (0.1 mg/kg). Patients considered eligible for MTX treatment of tubal pregnancy were those with unruptured tubal pregnancy

Assuntos
Feminino , Humanos , Gravidez , Alopecia , Medula Óssea , Gonadotropina Coriônica , Dermatite , Diagnóstico , Diarreia , Coração Fetal , Idade Gestacional , Saco Gestacional , Gengivite Ulcerativa Necrosante , Leucovorina , Metotrexato , Pneumonia , Gravidez Tubária , Salpingectomia , Ultrassonografia , Vômito
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA